Updates and corrections
If you think an answer is wrong, email hello@pharmrevise.co.uk and say which question. This page lists the corrections we have recorded to questions in the question bank since 24 September 2026.
Dates are when each change was recorded, which may be earlier than the day it appeared on the site. No question text is shown here. The list starts from 24 September 2026, the first recorded version. It does not mean nothing changed before then.
Corrections to questions
October 2026
- Corrected four questions, replaced an eye drop question that had more than one right answer with a new one on contact lenses, and removed the theme line from the start of extended matching questions. The answers to the four corrected questions did not change. One question out, one in, so the number of questions did not fall.
- Replaced a responsible pharmacist question whose answer changed when new rules on handing out dispensed medicines took effect in January 2026. One question out, one in, so the number of questions did not fall.
- Updated 23 type 2 diabetes questions to NICE's February 2026 guideline, including five changed answers. Two were retired and replaced, so the number of questions did not fall.
- Updated five questions to current NICE guidance, and retired two that taught a NICE diabetes rule withdrawn in February 2026.
- Corrected: a statin counselling question now asks about the risk a patient's own history raises, and the oxygen flow rate in three cluster-headache questions now reads 12–15 litres/minute.
- One question's source line now names the medicine rather than a retailer.
- Corrected 11 questions: wording in the question or explanation was changed for 11 questions, and the options for 2 of them.
- One Shelves explanation was reworded so that it does not read as a dose instruction.
- Corrected four questions that had more than one defensible answer or an unstated assumption (morphine diluent, stable-angina monotherapy, local anaesthetic choice, UTI in pregnancy).
- Seven extended-matching questions had a stem or explanation that allowed more than one reasonable answer, contradicted its own key, or understated a licensing restriction. The wording is fixed and sources are added; the answers are unchanged.
- We corrected three questions: two were rewritten where the wording or the answer options were unclear, and one about how long new medicines carry the black triangle now cites MHRA. Four extended-matching theme lines were reworded so they no longer hint at the answer.
- 8 questions were rewritten after a source check, including a warfarin induction dose that did not account for the patient being older; 3 of them had answers that did not match the guidance. 1 question about an injection that is not sold in the UK was removed.
- 2 dyspepsia questions were rewritten: where aspirin or an NSAID must continue, the answer is now to continue it with gastroprotection, as NICE advises. 1 near-duplicate question was removed.
- 2 antidepressant questions were removed: one had more than one defensible answer and one had the wrong answer. 2 others now credit NICE guidance; their answers did not change.
- Theme lines on 8 extended-matching questions now name their topic area, and 2 more were tidied.
- Explanation revised on 1 question about a pharmacy blood pressure service. The answer did not change.
- Theme lines on 9 extended-matching questions now name their topic area, and topic labels were updated on 3 questions.
- 20 questions corrected after a consistency review of stems, answers and explanations. The explanation was fixed on all 20, the stem on 15 and the options on 10, and the answer was changed or reworded on 8.
- 16 questions corrected. The stem, options or explanation was fixed on each, and the answer was changed or reworded on 9. 3 new questions were added at the same time.
- 2 questions were withdrawn pending a rewrite, one because its answer was not the best-supported option and one because it did not fit its setting.
- 4 questions updated after a review of changed rules. 5 answer options were changed across them, and the answer changed on 2.
- Explanations revised on 4 questions where they described a rule that has since been superseded or stated it wrongly. The answers did not change.
- 3 new questions were added.
- 3 extended-matching questions were withdrawn because more than one option could be right.
September 2026
- Wording clarified on 1 question where a stem could be misread. The answer did not change.
- 1 question was reworded so that its scenario reads consistently. The text of its correct option changed.
- Lead-in wording clarified on 3 questions. The answers did not change.
- 1 extended-matching question now states the results it asks about, so that only one option fits. A companion question covering the other direction was added.
- Wording clarified on 3 questions where a stem or an option was ambiguous. The text of the correct option changed on 1 of them.
- Wording clarified on 2 questions where a rule could be misread. The answers did not change.
- 7 questions were removed from the free trial set after a recheck, and 7 others were added.
Other updates
October 2026
- The privacy notice and terms of use were updated.
- The plan to your sitting now works out your pace from all your answers since you started, not just the last week.
- 103 new questions on the medicines most often prescribed in England.
- 53 new questions added to the bank.
- Our terms of use were updated on 25 October 2026: section 6 now covers PharmRevise's own public posts and links to them.
- Members' calculation practice now has at least five question patterns in each of our 16 calculation topics, from doses and dilutions to pharmacokinetics and health economics.
- Sign-up, sign-in and password emails now link to a confirmation page on this site.
- Added three new questions to replace retired ones: stopping GLP-1 receptor agonists, first-line treatment of type 2 diabetes, and fever in a baby under 3 months.
- The practice calculation for a reducing-dose course now sets out its working in fewer steps.
- Questions sourced from NICE guidance now show NICE's attribution, and the terms of use explain how NICE content is used.
- Shelves has six more daily puzzles.
- Practice calculations now show the number at each step of the worked solution.
- The number-needed-to-treat practice calculation now shows the number at each step of its working.
- Shelves has nine new daily puzzles, and its page now credits the Open Government Licence for the public sector information it uses.
- The Enter key in Generic Guess is now green and on the right, with Backspace on the left.
- Questions are now filed under the area their content belongs to, so Mastery by area reflects the right topics. 612 questions moved; no question or answer changed.
- The privacy notice was updated.
- You can now set a password from the Account screen.
- Signing up now ends on a confirmation screen.
- The bot check is paused while we fix a problem that stopped sign-ups completing in Safari.
- The landing page follows the light or dark setting from the app.
- The app has a new layout.
- The landing page has a new design.
- New typefaces and a refreshed style across the site.
- A short optional question asks how you heard about PharmRevise. The privacy notice was updated.
- 19 questions added to the bank.
- 156 questions added to the bank.
- Signed-in users can play the previous days' games.
- The daily games are now in the app.
- Every account with a confirmed email address can now open the full question bank. The privacy notice and terms of use were updated.
- Generic Guess now shows revision clues.
- Generic Guess answers now run from 5 to 12 letters.
- Fixed: the header title no longer overlaps the tabs.
- A second daily game, Stemmed, was added. The privacy notice was updated.
- A games page opened with a daily game, Generic Guess.
- The privacy notice was updated.
- The privacy notice was updated.
- You can now leave a comment on a question. The privacy notice and terms of use were updated.
- A dark mode switch was added.
- Fixed: on phones, the last answer option could be hidden under the bars.
- Revision guides and a How to use page were added.
- Progress has a new summary card.
- The score and evidence rings on Progress are clearer.
September 2026
- 40 more calculations added to the sampler.
- Calculation answers now show a fixed number of decimal places.
- A free calculations sampler is available. The privacy notice and terms of use were updated.
- Answer options are now shuffled.
- The privacy notice and terms of use were updated.
- A Progress dashboard was added.
- 29 questions added to the bank.
- 23 questions added to the bank.
- 116 questions added to the bank.
- Fixed: the due-now count on Progress now matches the review queue.
- Fixed: the header no longer sits under the phone status bar.
- Shared links to PharmRevise now show a preview image and description.
- The sign-in screen has a switch between Sign in and Create account.
- A bot check was added to sign-in, sign-up, email link and password reset. The privacy notice was updated.
- A new page shows how to add PharmRevise to your home screen.
- The privacy notice and terms of use were updated.
- 333 questions added to the bank.
- Sign-up asks you to confirm your password and choose your sitting, and Progress shows change arrows and a trend chart.
- Accounts can now save your progress.
- Anyone can now create an account. New accounts confirm their email address.
- The high, medium and low weighting labels were replaced by a new ordering.
- Fixed: on phones, the tab bar covered the Next button so it could not be tapped.
Not affiliated with the General Pharmaceutical Council. PharmRevise is for revision only and is not clinical advice.